医療薬学
Online ISSN : 1882-1499
Print ISSN : 1346-342X
ISSN-L : 1346-342X
一般論文
がん疼痛に対する高用量アセトアミノフェンの有効性と肝障害への影響
宮原 強小杉 寿文八谷 由貴鵜池 直邦佐藤 英俊松永 尚
著者情報
ジャーナル フリー

2016 年 42 巻 9 号 p. 605-612

詳細
抄録

The Japanese Society for Palliative Medicine has published a Clinical Practice Guideline for cancer pain management. In this Guideline, high-dose acetaminophen (2.4-4.0 g/day) is recommended to treat cancer pain. However, the effect of acetaminophen at different high doses on cancer patients has not been reported in Japan. This study was conducted to retrospectively investigate the effects of different high doses of acetaminophen on patients with cancer pain who were treated, as well as on the hepatic toxicity. Patients were divided into three groups who received acetaminophen at 2.4 g/day (n = 45), 3.2 g/day (n = 46), and 4.0 g/day (n = 20), respectively. Pain was scored according to the numeric rating scale (NRS). No significant differences were observed between the 2.4 g group, 3.2 g group and 4.0 g group regarding the incidence of Grade 2/3 hepatic toxicity (4.4% vs 4.3% vs 5.0%, respectively; P = 0.993). In contrast, significant differences in the NRS score were observed before and after acetaminophen administration in the 3.2 g group (n = 18) and 4.0 g group (n = 9), but not in the 2.4 g group (n = 16). The mean difference in the NRS score was 2.11 (P = 0.001) in the 3.2 g group, 1.56 (P = 0.028) in the 4.0 g group, and 0.44 (P = 0.297) in the 2.4 g group, respectively. In this research, acetaminophen administration at the dose of 3.2, 4.0 g a day was effective for the treatment of cancer pain.

著者関連情報
© 2016 日本医療薬学会
次の記事
feedback
Top